Abstract LBA046: Neoadjuvant and Adjuvant Capmatinib in Resectable Non-Small Cell Lung Cancer With MET Exon 14 Skipping Mutation or High MET Amplification: GEOMETRY-N Trial
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. e20524-e20524
◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 15
(1)
◽
pp. e8-e10
◽
Keyword(s):
Keyword(s):
Keyword(s):